It's all gone rather quiet re the China trial. I just hope it's the calm before the storm. I can't wait to see the official results of this trial.
It's all gone rather quiet re the China trial. I just hope it's the calm before the storm. I can't wait to see the official results of this trial.
Calm before the storm is a pretty much right on.
Can't wait until published and the mountain of data is available to everyone.
"That's not smog! It's SMUG!! " - randy marsh, southpark
"what???? , you don't 'all' wear a poop sac?.... DAMNIT BONNIE, YOU LIED TO ME ABOUT THE POOP SAC!!!! "
2010 SCINet Clinical Trial Support Squad Member
Please join me and donate a dollar a day at http://justadollarplease.org and copy and paste this message to the bottom of your signature
I don't know how much time it takes to publish a paper once submitted.
so the paper has already been submitted ?Waiting for publication?Or no?
"That's not smog! It's SMUG!! " - randy marsh, southpark
"what???? , you don't 'all' wear a poop sac?.... DAMNIT BONNIE, YOU LIED TO ME ABOUT THE POOP SAC!!!! "
2010 SCINet Clinical Trial Support Squad Member
Please join me and donate a dollar a day at http://justadollarplease.org and copy and paste this message to the bottom of your signature
6 month is not uncommon. there is time for peer review and the author's response to peer comments. journals typically show three dates - submitted, accepted, and published. The Harkema paper with the excellent estim results was submitted September 2013 and just published in April 2014.
T5/6, ASIA A, injured 30 Nov 08
Future SCI Alumnus.
I don't want to dance in the rain, I want to soar above the storm.
All I know is that the FDA must respond in a set amount of time. I can't remember offhand, but if you follow any of the spinal cord injury therapeutic biotech companies – they announce when they are submitting and when they receive information… Everything is available on their website to keep investors and consumers aware.
I think it is easy to keep track of news and progress when a company is public. I imagine a foundation could manage their pr in the same capacity.
Jim, check http://www.accessdata.fda.gov/script...21:5.0.1.1.3.3
It probably is different for a specialized drug, biomaterial or medical device. But there's tons of information here maybe you could find your answer